Watson, Antares in pact to market gel for overactive bladder
Watson Pharmaceuticals Inc. and Antares Pharma Inc. have entered into an exclusive licensing agreement for Watson to commercialize Antares’ topical oxybutynin gel product in the United States and Canada.